{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:09:58Z","timestamp":1778724598053,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA229811"],"award-info":[{"award-number":["R01 CA229811"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["CA262393"],"award-info":[{"award-number":["CA262393"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA237602"],"award-info":[{"award-number":["R01 CA237602"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajpath.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:39:05Z","timestamp":1772177945000},"page":"1133-1146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidermal Growth Factor Receptor\/KIT-Linked Proliferative Bias in Normal Breast Lobules from Matched Non-Hispanic Black and White Women Is Rapidly Reversible by Receptor Tyrosine Kinase Inhibition"],"prefix":"10.1016","volume":"196","author":[{"given":"Joshua W.","family":"Ogony","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7511-6169","authenticated-orcid":false,"given":"Nicole","family":"Cruz-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-8840","authenticated-orcid":false,"given":"Laura","family":"Pacheco-Spann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy C.","family":"Degnim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey J.","family":"Winham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-8808","authenticated-orcid":false,"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-8784","authenticated-orcid":false,"given":"Derek C.","family":"Radisky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2026.02.003_bib1","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","article-title":"Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer","volume":"24","author":"Haffty","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/cncr.22836","article-title":"Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database","volume":"110","author":"Morris","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2026.02.003_bib4","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajpath.2026.02.003_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1443399","article-title":"Racial\/ethnic differences in the clinical presentation and survival of breast cancer by subtype","volume":"14","author":"Nhim","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1038\/s41467-025-59144-z","article-title":"The clinical and molecular landscape of breast cancer in women of African and South Asian ancestry","volume":"16","author":"Thorn","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1158\/1055-9965.EPI-20-0556","article-title":"Epidemiology of basal-like and luminal breast cancers among Black women in the AMBER Consortium","volume":"30","author":"Benefield","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajpath.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10549-015-3474-4","article-title":"Race-associated biological differences among luminal a breast tumors","volume":"152","author":"D'Arcy","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ajpath.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/15592294.2015.1121362","article-title":"Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women","volume":"10","author":"Song","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/j.ajpath.2026.02.003_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221075458","article-title":"The DNA damage repair landscape in Black women with breast cancer","volume":"14","author":"Mazumder","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ajpath.2026.02.003_bib11","first-page":"570","article-title":"Immunohistochemical expression of epidermal growth factor receptor and c-Kit in triple negative breast cancer","volume":"26","author":"Ahmed","year":"2016","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.ajpath.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/ijms20030667","article-title":"The proliferative and apoptotic landscape of basal-like breast cancer","volume":"20","author":"Alexandrou","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","article-title":"Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer","volume":"21","author":"Burstein","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3390\/cells10102768","article-title":"Functional proteomic profiling of triple-negative breast cancer","volume":"10","author":"Gromova","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-0463.2008.01024.x","article-title":"Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women","volume":"116","author":"Nalwoga","year":"2008","journal-title":"Apmis"},{"key":"10.1016\/j.ajpath.2026.02.003_bib17","first-page":"4280","article-title":"C-kit and PDGFRA gene mutations in triple negative breast cancer","volume":"7","author":"Zhu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.ajpath.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1074\/jbc.M110.182642","article-title":"Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells","volume":"286","author":"Chaix","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","article-title":"Stem cell factor receptor\/c-Kit: from basic science to clinical implications","volume":"92","author":"Lennartsson","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7150\/ijbs.6087","article-title":"The C-kit receptor-mediated signal transduction and tumor-related diseases","volume":"9","author":"Liang","year":"2013","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ajpath.2026.02.003_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/10428199709058310","article-title":"Stem cell factor, the JAK-STAT pathway and signal transduction","volume":"27","author":"Linnekin","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ajpath.2026.02.003_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119359","article-title":"Control of cell metabolism by the epidermal growth factor receptor","volume":"1869","author":"Orofiamma","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.ajpath.2026.02.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188631","article-title":"A holistic view on c-Kit in cancer: structure, signaling, pathophysiology and its inhibitors","volume":"1876","author":"Pathania","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.ajpath.2026.02.003_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024064","article-title":"C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation","volume":"6","author":"Phung","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/10245332.2018.1444564","article-title":"Cell proliferation and inhibition of apoptosis are related to c-Kit activation in leukaemic lymphoblasts","volume":"23","author":"Reyes-Sebastian","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.ajpath.2026.02.003_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/cells13010047","article-title":"Targeted inhibitors of EGFR: structure, biology, biomarkers, and clinical applications","volume":"13","author":"Shaban","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1007\/s10620-007-9759-7","article-title":"Stem cell factor\/c-kit receptor signaling enhances the proliferation and invasion of colorectal cancer cells through the PI3K\/Akt pathway","volume":"52","author":"Yasuda","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"Suppl 6","key":"10.1016\/j.ajpath.2026.02.003_bib30","doi-asserted-by":"crossref","first-page":"vi26","DOI":"10.1093\/annonc\/mdm220","article-title":"Lapatinib in breast cancer","volume":"18","author":"Bilancia","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajpath.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/jnci\/djn216","article-title":"Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain","volume":"100","author":"Gril","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ajpath.2026.02.003_bib32","article-title":"EGFR-directed antibodies promote HER2 ADC internalization and efficacy","volume":"5","author":"Gupta","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ajpath.2026.02.003_bib33","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1158\/0008-5472.CAN-05-1182","article-title":"Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells","volume":"66","author":"Konecny","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/sj.bjc.6604278","article-title":"Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells","volume":"98","author":"Konecny","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ccell.2019.04.006","article-title":"Ripretinib (DCC-2618) is a switch control kinase inhibitor of a broad spectrum of oncogenic and drug-resistant KIT and PDGFRA variants","volume":"35","author":"Smith","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2026.02.003_bib36","doi-asserted-by":"crossref","DOI":"10.3791\/50011-v","article-title":"Processing of human reduction mammoplasty and mastectomy tissues for cell culture","author":"Labarge","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2026.02.003_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101065","article-title":"A gene set enrichment analysis for cancer hallmarks","volume":"15","author":"Menyhart","year":"2025","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.ajpath.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2026.02.003_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:43:11Z","timestamp":1778722991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944026000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0002944026000416"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.02.003","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal Growth Factor Receptor\/KIT-Linked Proliferative Bias in Normal Breast Lobules from Matched Non-Hispanic Black and White Women Is Rapidly Reversible by Receptor Tyrosine Kinase Inhibition","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Investigative Pathology.","name":"copyright","label":"Copyright"}]}}